After 10 years, members of the 4D Nucleome consortium have successfully completed the first phase of a project that aims to ...

A flutter of blue and yellow darts through a field in late May. Trees, shrubs and summer flowers fill the landscape. A ...

More than a decade after the first Neanderthal genome was sequenced, scientists are still working to understand how ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and medicine, like insulin.

NEW YORK CITY, NY / ACCESS Newswire / December 18, 2025 / Classover Holdings, Inc. (NASDAQ:KIDZ)(NASDAQ:KIDZW) ("Classover" or the "Company"), a leading provider in K-12 educational AI, today ...

India may be embracing GLP-1 weight-loss drugs, but healthtech startup Fittr is standing against the trend. With the launch ...

Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the ...

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Data demonstrates the significant and sustained tumor regression achieved by the CAPTN-3 platform across two distinct tri-specific antibodies, IM1240 and IM1305, targeting different tumor antigens ...

Insilico Medicine has developed a new class of small molecule inhibitors targeting diacylglycerol kinase alpha (DGKα) designed to restore T cell function and overcome resistance to immune checkpoint ...

The Colossal Foundation, the 501(c)(3) nonprofit arm of Colossal Biosciences, the world's first de-extinction company, today announced an additional $50 million in secured funding?bringing its total ...

This article was featured in the One Story to Read Today newsletter. Sign up for it here. The historian Rob Boddice sat cross-legged on his couch in Montreal on a frigid day last winter and conjured ...